VISTA is an immune checkpoint molecule for human T cells.
about
Genetics and biology of pancreatic ductal adenocarcinomaNovel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialImmune checkpoint inhibitors: therapeutic advances in melanomaNovel Immune Check-Point Regulators in Tolerance MaintenanceBeyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsImmune checkpoint blockade: a common denominator approach to cancer therapyThe novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity.Mechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic Antigens.Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.Selective Involvement of the Checkpoint Regulator VISTA in Suppression of B-Cell, but Not T-Cell, Responsiveness by Monocytic Myeloid-Derived Suppressor Cells from Mice Infected with an Immunodeficiency-Causing RetrovirusInhibitory receptors as targets for cancer immunotherapyImmune based therapy for melanomaCoinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.A New VISTA on combination therapy for negative checkpoint regulator blockade.Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.Blocking the VISTA pathway enhances disease progression in (NZB × NZW) F1 female mice.Reversing T-cell Dysfunction and Exhaustion in Cancer.Immunoregulatory functions of VISTA.Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment.Immunosuppression in liver tumors: opening the portal to effective immunotherapy.T cell exhaustion: from pathophysiological basics to tumor immunotherapy.VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy.Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines.New B7 Family Checkpoints in Human Cancers.Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis.CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8+ TEM and CD8+ TRM Cells within Infected Tissues Allows Efficient Protection against Recurrent Herpesvirus Infection and Disease.Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma.Programmed death one homolog maintains the pool size of regulatory T cells by promoting their differentiation and stability.VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responses.Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200.A family-based genome-wide association study of chronic rhinosinusitis with nasal polyps implicates several genes in the disease pathogenesis.VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.VISTA Deficiency Accelerates the Development of Fatal Murine Lupus Nephritis.Spatially resolved and quantitative analysis of VISTA/PD-1H as a novel immunotherapy target in human non-small cell lung cancer.Gamma-delta (γδ) T cells: friend or foe in cancer development?The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation.Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword.Immune system and melanoma biology: a balance between immunosurveillance and immune escape.
P2860
Q26765438-34BEF90A-53D4-49D6-8B31-DE0221EF036FQ26769884-3CB87D89-ABD0-4980-999D-ADB8413ED2CCQ26775591-634B14DD-924D-4E69-83E0-FAE994885E21Q26782789-06DC4B7E-BD8A-452B-BBA8-4D4C1E967503Q26782799-64AE47D5-AE6C-4755-B777-45D2CD4A002DQ28083981-B9DCEF61-FCA0-43C8-AF15-85FB12B0681EQ33632116-AE0F3D2B-0908-453F-AB1B-91FF864F9766Q34384017-687F5D4D-400A-4CE7-8054-9CC4F24E9FE2Q35613336-8CE55CAD-5D9C-4DEC-99C1-53ECCAC9DF25Q35669414-66513254-74C2-43F8-A54C-1116D99752DDQ35973689-3EE6DBF2-452A-4711-8B6D-1AF864F4977AQ35995373-727A63D5-6E82-4D74-BD23-F28B2A3E3B0DQ36876757-CA683D30-B765-4521-9863-B8BEBE63E647Q36998864-7AC0EB2E-A2AA-45CE-A02B-B141D2B22DA1Q37158481-69E3E272-F80B-4088-B695-3B3B4725B9E3Q37517581-72F5EA0B-624E-44D8-B941-2FE6275830CDQ38636569-4EF95F50-B895-4C3F-A743-9CCB61CF07DAQ38704089-14BF3047-5648-4E48-84D1-3474A437D453Q38809776-FFC65BFE-FE9F-408E-94E4-8EAC9EE736A8Q38930123-A97BF481-02F8-43D3-95D7-AD5378B37E92Q38996594-88E52F5F-27EE-4A76-A533-57685E917C73Q39026963-3F201300-C0D6-4996-84E2-2C635EBEEEC4Q39078341-6C1C13C7-1F7A-4B3A-B759-6EB4B1546458Q39181190-AD3F5F07-48A4-4826-8C1E-C89AA61F94AEQ39189908-3B35C82B-48C0-4851-B528-6DCF4D9133D6Q39416195-62FC8469-C87E-4C10-ACCC-5C698D5339B2Q40216414-D153C9A2-7DF8-4074-969F-F88E93167FB2Q40216595-F2E54269-B976-450B-A2EE-2D4AD3880338Q40446457-1FA9DA5A-CD5F-4F65-9753-1C5597F456EEQ41075955-1BF6583B-34FD-4A2B-8C9D-2C620D519519Q41863599-3D0902CE-FD59-4769-9C78-2E1833F6FA92Q46971015-08D01076-7774-4644-B727-42E0205FB094Q47105919-22663B93-2729-4C6E-8D80-13377E321930Q47139628-4773B9C1-78B6-4B3E-8114-0D323CED24D4Q47151685-EF480A6F-7F99-4EC2-BEB9-996480CEB151Q47332473-59A0D564-118A-4C87-A5C5-3A28425E39D9Q47742552-1663AC3C-3BE8-4400-B323-8DFA08380B76Q48156081-BD69D6C5-9E9E-47DB-A9C6-CA776F3A31FFQ48273861-761ECE01-EDC5-47C5-BF79-2D62257E93C6Q49166036-733EBA30-3265-4137-8AD8-B59A00CE1642
P2860
VISTA is an immune checkpoint molecule for human T cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
VISTA is an immune checkpoint molecule for human T cells.
@ast
VISTA is an immune checkpoint molecule for human T cells.
@en
VISTA is an immune checkpoint molecule for human T cells.
@nl
type
label
VISTA is an immune checkpoint molecule for human T cells.
@ast
VISTA is an immune checkpoint molecule for human T cells.
@en
VISTA is an immune checkpoint molecule for human T cells.
@nl
prefLabel
VISTA is an immune checkpoint molecule for human T cells.
@ast
VISTA is an immune checkpoint molecule for human T cells.
@en
VISTA is an immune checkpoint molecule for human T cells.
@nl
P2093
P2860
P921
P1433
P1476
VISTA is an immune checkpoint molecule for human T cells.
@en
P2093
Arief A Suriawinata
Eirini Pantazi
J Louise Lines
Justin Mak
Lorenzo F Sempere
Marc S Ernstoff
Randolph Noelle
Sabrina Ceeraz
Samuel O'Connell
P2860
P304
P356
10.1158/0008-5472.CAN-13-1504
P407
P577
2014-04-01T00:00:00Z